Science Current Events | Science News | Brightsurf.com
 
Email a Friend Send to a friend
Printer Friendly Print Operations research promises continued gains for HIV treatment in resource-limited countries

Operations research promises continued gains for HIV treatment in resource-limited countries

August 25, 2008

In the past 10 years, the global campaign to expand treatment for millions of people with AIDS living in resource-limited countries, especially in sub-Saharan Africa, has gained substantial commitments in public and private financing, and has made major strides in making treatment available to those who need it. A new collaborative study by researchers at Weill Cornell Medical College and the Clinton Foundation HIV/AIDS Initiative explores how to combine engineering science with medical care to guarantee the long-term success of these treatment programs.

In an article published online this month in the BMC Health Services Research journal, the researchers show how the use of sophisticated mathematical modeling approaches used in the field of operations research can help maximize the efficient use of limited resources, notably antiretroviral drugs and medical personnel.




"Operations research offers a powerful set of tools that have been used successfully in everything from World War II to Wal-Mart-style logistics planning. These tools ought to be used to increase the success of existing programs and to help expand access to HIV care and treatment in resource-limited countries," says lead author Dr. Wei Xiong, instructor in public health at Weill Cornell Medical College. "For example, operations research could help with the planning of a national drug distribution system, or with predicting the demand for services at local clinics and the best ways to staff them."

"To date, HIV treatment scale-up has appropriately focused first on policy-level issues, such as program initiation and costs, and secondarily on operational-level issues," adds co-investigator Dr. Nathaniel Hupert, associate professor of public health at Weill Cornell Medical College and associate attending physician at NewYork-Presbyterian Hospital/Weill Cornell Medical Center. "Now that many programs are in place, the potential gains from improved planning are great, especially given the high cost of antiretroviral drug therapy."

Another important, looming problem in resource-limited settings, the authors write, is the lack of sufficient health care workers to diagnose and treat the millions of people living with HIV.

Beginning in 2005, the Weill Cornell and the Clinton Foundation researchers created a series of computer simulations to estimate resource requirements and treatment capacity scale-up at an HIV clinic. This year they used a simulation model to predict the amount of physician person-hours saved by shifting some duties to nurses for HIV clinics in Rwanda. This model suggests that if task-shifting were scaled up from a pilot program in three health centers to the national level, it could reduce the demand on public-sector physicians for HIV services by up to 78 percent.

"The analysis suggested that implementation of such a program could allow the government of Rwanda to scale-up HIV treatment without overburdening its existing health-care system," Dr. Xiong comments.

According to the new paper, another area ripe for improvements is the management of laboratory resources, which are often underutilized or not maintained. When there is an equipment breakdown, it often takes a prohibitively long time to get replacement parts or qualified repair technicians.

"The unique advantage of operations research is that it gives us the ability to evaluate and optimize outcomes of various scenarios -- such as determining the best approach for the management of lab equipment repair -- without impacting patients," explains Dr. Xiong. "Once we have the evidence for a new approach, a good case can be made that it should be implemented as policy, although any initiative should take into account the environments in which the projects are to be carried out, with all necessary ethical, cultural and political considerations."

The need for better resource planning in HIV treatment has been noted by the President's Emergency Plan for AIDS Relief (PEPFAR) program, which writes of the importance of "placing greater emphasis on long-term strategic planning and increasing the attention and resources directed to capacity building for sustainability."

Approximately 95 percent of patients with HIV/AIDS live in developing countries. It is estimated that close to 3 million people, or 31 percent of those living with HIV in resource-limited nations, have access to antiretroviral treatment, a substantial improvement from 5 percent coverage just five years ago.

"While laudable progress has been made, the great majority of HIV patients are still under-treated or untreated," says Dr. Hupert. "We feel that operations research provides one of the tools to make sure progress continues."

"This area of research -- and specifically this and other projects led by Drs. Hupert and Xiong -- shows how fields such as the engineering sciences can contribute to solving medical and public health problems," says Dr. Alvin I. Mushlin, chairman and Nanette Laitman Distinguished Professor of Public Health at Weill Cornell Medical College, and Public Health Physician-in-Chief at NewYork-Presbyterian Hospital/Weill Cornell Medical Center.

New York- Presbyterian Hospital/Weill Cornell Medical Center/Weill Cornell Medical College



Related HIV Treatment Current Events and HIV Treatment News Articles HIV Treatment Current Events and HIV Treatment News RSS HIV Treatment Current Events and HIV Treatment News RSS
Integrating antiretroviral therapy with TB treatment for co-infections reduces mortality
A South African treatment study conducted by researchers in the Department of Epidemiology at the Mailman School of Public Health shows that mortality among TB-HIV co-infected patients can be reduced by a remarkable 55%, if antiretroviral therapy (ART) is provided with TB treatment at the same time.

HIV drug maraviroc effective for drug-resistant patients
As many as one quarter of HIV patients have drug resistance, limiting their treatment options and raising their risk for AIDS and death.

Scientists unmask key HIV protein, open door for more powerful AIDS drugs
University of Michigan scientists have provided the most detailed picture yet of a key HIV accessory protein that foils the body's normal immune response.

Researchers Evaluate Cost-Effectiveness of Genetic Screening to Guide Initial HIV Treatment
A major study from a team of researchers from Weill Cornell Medical College and Massachusetts General Hospital has found that a recent change to HIV-treatment guidelines recommending genetic screening is cost-effective under certain conditions.

Certain HIV treatment less effective when used with anti-TB therapy
Patients receiving rifampicin-based anti-tuberculosis therapy are more likely to experience virological failure when starting nevirapine-based antiretroviral therapy, an HIV treatment that is widely used in developing countries because of lower cost, than when starting efavirenz-based antiretroviral therapy.

Researchers disprove long-standing belief about HIV treatment
Researchers at Wake Forest University Baptist Medical Center have disproved a long-standing clinical belief that the hepatitis C virus slows or stunts the immune system's ability to restore itself after HIV patients are treated with a combination of drugs known as the "cocktail."

Psychosocial issues affect HIV/AIDS treatment outcomes: UNC researcher
Psychosocial influences such as stress, depression and trauma have been neglected in biomedical and treatment studies involving people infected with HIV, yet they are now known to have significant health impacts on such individuals and the spread of AIDS, according to a University of North Carolina at Chapel Hill scientist.

Anti-HIV gel proven safe, tolerable for women
An experimental anti-HIV gel is safe for women to use on a daily basis, according to researchers at the University of Alabama at Birmingham (UAB) and the University of Pittsburgh School of Medicine.

Simple strategy could prevent half of deadly tuberculosis infections
By using a combination of inexpensive infection control measures, hospitals around the world could prevent half the new cases of extensively drug resistant tuberculosis (XDR TB), according to a new study in The Lancet by researchers at Yale School of Medicine.

Implications of the new HIV estimate for India
The 2007 UNAIDS/WHO AIDS epidemic update released last week has revised the global estimate of HIV/AIDS primarily due to a major reduction of the estimate for India to 2.5 million people living with HIV/AIDS, which is less than half of the previous official estimate of 5.7 million people.
More HIV Treatment Current Events and HIV Treatment News Articles


Nutrition and HIV: A New Model for Treatment
by Mary, M.D. Romeyn

Treating HIV with Nutrition Nutrition and HIV addresses the issues of nutrition and HIV from the perspective of the patient as well as the physician. Everyone who is interested in the problems of--and solutions to--nutritional therapy in HIV owes it to themselves to read this book. --Paul A. Volberding, M.D., director, Center for AIDS Research, San Francisco This reference book...



Application of Causal Inference Methods to Improve Treatment of HIV Infection
by Maya Petersen

Advances in causal inference have improved the ability of statistical methods to answer practical questions in epidemiology and clinical research. In particular, the counterfactual framework and marginal structural models have provided the basis for practical and theoretical advances in the statistical estimation of causal parameters. The dissertation focuses on the development and application of...



Cognitive-Behavioral Stress Management for Individuals Living with HIV: Facilitator Guide (Treatments That Work)
by Michael J. Antoni, Gail Ironson, Neil Scheiderman

For individuals living with HIV, stress can have a critical impact on emotional and physical well-being. Many HIV-infected individuals feel a loss of control over their lives, experience social isolation, and may suffer from anxiety and depression. Stress has been shown to decrease immune functioning, which is a significant concern for HIV-infected individuals. Written by the developer of the...



HIV Treatment Adherence: Challenging for Social Services (Journal of HIV/AIDS & Social Services) (Journal of HIV/AIDS & Social Services)
by Lana Sue Ka'opua, Nathan L. Linsk

Learn the latest social service interventions to promote HIV medication adherence Highly Active Antiretroviral Therapy (HAART) can significantly improve the health outcomes of people living with HIV. Still, benefits rely on the steady adherence to the medication regimen as prescribed. Social Work and HIV: Challenges to Treatment Adherence is a practice-friendly resource with...



The Geometry of Care: Linking Resources, Research, And Community to Reduce Degrees of Separation Between HIV Treatment And Prevention (Social Work in Health Care,) (Social Work in Health Care,)
by Dorothy(debbie) Indyk

An effective strategy to deal with the AIDS epidemic is to have a wide range of scientists, clinicians, front-line workers, and clients distribute theory, care, and resource knowledge geometrically through all levels. "The Geometry of Care" shows how to link bottom-up and top-down approaches to advance care, services, resources, training, theory, and policy analysis. Leading authorities draw upon...

Panel releases updated HIV treatment guide.(Infectious Diseases)(International AIDS Society): An article from: Internal Medicine News
by Sharon Worcester

This digital document is an article from Internal Medicine News, published by International Medical News Group on August 15, 2004. The length of the article is 696 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web...



Evaluating HIV/Aids Treatment Programs: Innovative Methods and Findings

Evaluating HIV/AIDS Treatment Programs offers new strategies for providing care for substance abusers with HIV/AIDS. This volume offers specific, proven programs designed to help underserved populations--including women, Latinos, Haitians, adolescents, and rural people--overcome linguistic, cultural, racial, and economic barriers to obtaining health care. It also offers specialized medical care...

Clinical Assessment And Treatment of HIV Rehabilitation of a Chronic Illness
by Mary Lou Galantino

Drug resistance, other patient factors called key to HIV treatment failures.(Infectious Diseases): An article from: Internal Medicine News
by Heidi Splete

This digital document is an article from Internal Medicine News, published by Thomson Gale on September 15, 2005. The length of the article is 628 words. The page length shown above is based on a typical 300-word page. The article is delivered in HTML format and is available in your Amazon.com Digital Locker immediately after purchase. You can view it with any web browser.Citation DetailsTitle:...



HIV/AIDS Treatment Drugs (Drugs: the Straight Facts)
by Brigid M. Kane

Drugs are everywhere--on our streets, in our homes, and in our schools--but the straight facts about drugs are...

© 2008 BrightSurf.com